Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals

Clinical and Experimental Immunology

Volumn 104, Issue 2, 1996, Pages 203-207

  Rosok B ^a,e   Voltersvik, P ^c   Bjerknes, R ^b   Axelsson, M ^d   Haaheim, L R ^b   Asjo B ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Clin Infect Dis Prev Travel Med   (Norway)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

Haemagglutination inhibition; HIV; Influenza; Vaccination; Viral load

Indexed keywords

CD4 ANTIGEN; INFLUENZA VACCINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA; INTRAMUSCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL; VACCINATION; VIREMIA; VIRUS REPLICATION;

EID: 0029873773     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.25732.x     Document Type: Article

References (27)

1. Giorgi JV. CD4 counts in relation to markers of immune activation. In: Janossy G, Autran B, Miedema F et al., eds. Immunodeficency of HIV infection and AIDS. Kärger, 1992.
2. Murphy P. Upper respiratory tract infections. Ch. 9.5 In: Harvey AMcG, Johns RJ, McKusick VA et al., eds. The principles and practice of medicine, 22nd edn. East Norwalk: Appleton & Lange, 1988.
3. Cohen JP, Macauley C. Susceptibility to influenza A in HIV-positive patients. JAMA 1989; 261:245.
4. Saffrin S, Rush JD, Mills J. Influenza in patients with human immunodeficiency virus infection. Chest 1990; 98:33-37.
5. Thurn JR, Henry K. Influenza A pneumonitis in a patient infected with the human immunodeficiency virus (HIV). Chest 1989; 95:807-10.
6. Wallace JM. Pulmonary infections in human immunodeficiency disease: viral pulmonary infections. Semin Respir Infect 1989; 4:147-54.
7. Prevention and control of influenza recommendations of the immunization practices advisory committee (ACIP). MMWR 1995;44:5-6.
8. + lymphocytes. AIDS 1994; 8:469-76.
9. Ho DD. HIV-1 viremia and influenza. Lancet 1992; 339:1549.
10. Yerli S, Wunderli W, Wyler CA et al. Influenza immunization of HIV-1 infected patients does not increase HIV-1 load. AIDS 1994; 8:1503-4.
11. O'Brien WA, Grovit-Farbas K, Namazi A et al. Human immunodeficiency virus-type I replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995; 86:1082-9.
12. Ancelle Park RA. Expanded European AIDS case definition. Lancet 1993; 341:441.
13. Leivestad T, Gaudernack G, Ugelstad J, Vartdal F, Thorsby E. Isolation of pure and functionally active T4 and T8 cells by positive selection with antibody-coated monosized magnetic microspheres. Transplant Proc 1987; XIX:265-7.
14. Åsjö B, Morfeldt-Månson L, Albert J, Biberfeld G, Karlsson A, Lidman K, Fenyö EM. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 1986; 2:660-2.
15. Fenyö EM. Morfeldt-Månson L, Chiodi F et al. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 1988; 62:4414-9.
16. + T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type I infection. J Virol 1991; 65:2019-23.
17. Sundqvist VA, Albert J, Ohlsson E, Hinkula J, Fenyö EM, Wahren B. Human immunodeficiency virus type I p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J Med Virol 1989; 29:170-5.
18. Kendal AP, Pereira MS, Skehel JJ. Concepts and procedures for laboratory based influenza surveillance. Washington DC: US Department of Health and Human Services, 1982.
19. Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutinin inhibition antibody in protection against challenge infection with influenza A and B viruses. J Hyg (Cambridge) 1972; 70:767-77.
20. Brokstad KA, Cox RJ, Olofsson J, Jonsson R, Haaheim LR. Parenteral influenza vaccination induces a rapid systemic and local immune response. J Inf Dis 1995; 171:198-203.
21. Bush CE, Donovan RM, Markowitz NP, Murray L, Baxa DM, Saravolatz LD. Changes in HIV viral load markers during oOpportunistic diseases. Paper 1236 in Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC. San Fransisco, 17-20 September 1995.
22. Lu W, Grassi F, Tourani JM, Erne D, Israel-Biet D, Andrieu JM. High concentration of peripheral blood mononuclear cells harboring infectious virus correlates with rapid progression of human immunodeficiency virus type-I related diseases. J Inf Dis 1993; 168:1165-8.
23. Fiscus SA, Heggem-Snow A, Troiani L, Wallmark E, Folds JD, Sheff B, van der Horst CM. Transient high titers of HIV-1 in plasma and progression of disease. J Acquir Immune Defic Syndr Hum Retrovir 1995; 9:51-57.
24. Testi R, D'Ambrosio D, De Maria R, Santoni A. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 1994; 15:479-83.
25. Chadwick EG, Chang G, Decker MD, Yogev R, Dimichele D, Edwards KM. Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1994; 13:206-11.
26. Nelson KE, Clements ML, Miotti P, Cohn S, Polk BF. The influence of human immunodeficiency virus (HIV) on antibody responses to influenza vaccines. Ann Intern Med 1988; 109:383-8.
27. Prevention and control of influenza recommendations of the immunization practices advisory committee (ACIP). MMWR 1995; 44:14-18.